| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S40618-017-0683-1 |
| P698 | PubMed publication ID | 28589383 |
| P50 | author | Sofia Pereira | Q39438351 |
| Jéferson Crespígio | Q81487419 | ||
| P2093 | author name string | D Pignatelli | |
| M A Dias | |||
| T L Mazzuco | |||
| L C L Berbel | |||
| R F Berbel | |||
| P2860 | cites work | The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis | Q22009936 |
| von Hippel-Lindau disease: a clinical and scientific review | Q24622030 | ||
| The spindle-assembly checkpoint in space and time | Q27860766 | ||
| von Hippel-Lindau disease | Q28180159 | ||
| Current development of mTOR inhibitors as anticancer agents | Q28255366 | ||
| The vertebrate primary cilium in development, homeostasis, and disease | Q29614609 | ||
| Identification of the von Hippel-Lindau disease tumor suppressor gene | Q29618644 | ||
| Biological and clinical impact of hemangioblastoma-associated peritumoral cysts in von Hippel-Lindau disease | Q30278444 | ||
| Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease | Q30360730 | ||
| Treatment of retinal capillary hemangioma | Q30858960 | ||
| Ophthalmological manifestations in VHL and NF 1: pathological and diagnostic implications | Q33214879 | ||
| Uptake of genetic testing and long-term tumor surveillance in von Hippel-Lindau disease | Q33523199 | ||
| VHL-gene deletion in single renal tubular epithelial cells and renal tubular cysts: further evidence for a cyst-dependent progression pathway of clear cell renal carcinoma in von Hippel-Lindau disease | Q33568494 | ||
| Central nervous system lesions in von Hippel-Lindau syndrome | Q33591720 | ||
| Presymptomatic diagnosis of von Hippel-Lindau disease with flanking DNA markers | Q33594795 | ||
| Long-term use of intravitreal bevacizumab (avastin) for the treatment of von hippel-lindau associated retinal hemangioblastomas | Q33811756 | ||
| Von Hippel-Lindau syndrome. A pleomorphic condition | Q33813972 | ||
| Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival | Q34021957 | ||
| Pilot trial of sunitinib therapy in patients with von Hippel-Lindau disease | Q34079864 | ||
| Genetic analysis of von Hippel-Lindau disease. | Q34098432 | ||
| Prospective evaluation of radiosurgery for hemangioblastomas in von Hippel-Lindau disease | Q34132624 | ||
| The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. | Q34530776 | ||
| Clinical features and natural history of von Hippel-Lindau disease | Q34639796 | ||
| Pheochromocytomas and paragangliomas in von Hippel-Lindau disease: a role for laparoscopic and cortical-sparing surgery | Q34671110 | ||
| von Hippel-Lindau disease: genetic, clinical, and imaging features | Q34723401 | ||
| Von Hippel-Lindau disease in a Newfoundland kindred | Q34726572 | ||
| Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease | Q34726998 | ||
| Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease | Q34740142 | ||
| The genetic basis of cancer of the kidney | Q35591611 | ||
| Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis | Q35753186 | ||
| Surgical outcomes in patients with endolymphatic sac tumors. | Q35849071 | ||
| CLINICALLY INVISIBLE RETINAL HEMANGIOBLASTOMAS DETECTED BY SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY AND FLUORESCEIN ANGIOGRAPHY IN TWINS. | Q36106014 | ||
| Pheochromocytoma Screening Initiation and Frequency in von Hippel-Lindau Syndrome | Q36339936 | ||
| Immunohistochemical markers of the hypoxic response can identify malignancy in phaeochromocytomas and paragangliomas and optimize the detection of tumours with VHL germline mutations | Q36594111 | ||
| Pancreatic neuroendocrine tumors: approach to treatment with focus on sunitinib | Q37130616 | ||
| Pazopanib therapy for cerebellar hemangioblastomas in von Hippel-Lindau disease: case report. | Q37275838 | ||
| VHL Disease | Q37787564 | ||
| Oxygen sensing, homeostasis, and disease | Q37914865 | ||
| Pancreatic lesions in von Hippel-Lindau disease? A systematic review and meta-synthesis of the literature. | Q37988747 | ||
| Everolimus and mTOR inhibition in pancreatic neuroendocrine tumors | Q38035844 | ||
| Precursor lesions of endocrine system neoplasms | Q38088098 | ||
| mTOR inhibitors in renal cell carcinoma | Q38280462 | ||
| Management of von hippel-lindau disease: an interdisciplinary review. | Q38297048 | ||
| Endocrine manifestations of von Hippel-Lindau disease. | Q38328199 | ||
| Targeted therapy for genetic cancer syndromes: Von Hippel-Lindau disease, Cowden syndrome, and Proteus syndrome | Q38366027 | ||
| Evaluation and management of pancreatic lesions in patients with von Hippel-Lindau disease | Q38794106 | ||
| Von Hippel-Lindau Disease: Genetics and Role of Genetic Counseling in a Multiple Neoplasia Syndrome. | Q38817715 | ||
| VHL loss causes spindle misorientation and chromosome instability. | Q39822734 | ||
| Von Hippel-Lindau disease: new strategies in early detection and treatment | Q40688491 | ||
| The natural history of renal lesions in von Hippel-Lindau disease: a serial CT study in 28 patients | Q42037233 | ||
| Simple renal cysts, atypical renal cysts, and renal cell carcinoma in von Hippel-Lindau disease: a lectin and immunohistochemical study in six patients | Q43485682 | ||
| Parasympathetic paragangliomas are part of the Von Hippel-Lindau syndrome. | Q43503400 | ||
| Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes | Q43601804 | ||
| Retinal capillary hemangioma: a comparison of sporadic cases and cases associated with von Hippel-Lindau disease | Q43753433 | ||
| Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype | Q44847029 | ||
| Inhibin-expressing clear cell neuroendocrine tumor of the ampulla: an unusual presentation of von Hippel-Lindau disease. | Q45937365 | ||
| Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline | Q46897538 | ||
| Outcome of twin babies free of Von Hippel-Lindau disease after a double-factor preimplantation genetic diagnosis: monogenetic mutation analysis and comprehensive aneuploidy screening. | Q48729486 | ||
| Mechanisms of morbid hearing loss associated with tumors of the endolymphatic sac in von Hippel-Lindau disease | Q50456835 | ||
| Cochlear implantation for hearing loss associated with bilateral endolymphatic sac tumors in von Hippel-Lindau disease | Q50457787 | ||
| Tumors of the endolymphatic sac in patients with von Hippel-Lindau disease: implications for their natural history, diagnosis, and treatment. | Q50473982 | ||
| Renal involvement in von Hippel-Lindau disease. | Q50999477 | ||
| Von Hippel-Lindau disease. | Q51971299 | ||
| Paraneoplastic erythrocytosis associated with an inactivating point mutation of the von Hippel-Lindau gene in a renal cell carcinoma. | Q52957775 | ||
| Endocrine pancreatic tumors in von Hippel-Lindau disease: clinical, histological, and genetic features. | Q53407685 | ||
| Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients. | Q53623621 | ||
| Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine tumors (PNETs) | Q58417136 | ||
| Radiosurgery for hemangioblastoma: Results of a multiinstitutional experience | Q61832859 | ||
| Pancreatic involvement in von Hippel–Lindau disease | Q62929393 | ||
| Papillary cystadenoma of the mesosalpinx in von Hippel-Lindau disease | Q68264421 | ||
| Renal cell carcinoma in von Hippel-Lindau syndrome | Q69741072 | ||
| Renal cysts, renal cancer and von Hippel-Lindau disease | Q71974434 | ||
| Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicenter study | Q72241820 | ||
| The clinical and pathological manifestations of renal tumors in von Hippel-Lindau disease | Q72820743 | ||
| von Hippel-Lindau disease | Q73567751 | ||
| Pheochromocytoma in von hippel-lindau disease: distinct histopathologic phenotype compared to pheochromocytoma in multiple endocrine neoplasia type 2 | Q74454015 | ||
| pVHL: a multipurpose adaptor protein | Q81470388 | ||
| Endolymphatic sac tumor and von Hippel-Lindau disease in a single family | Q82485118 | ||
| Von hippel-lindau disease | Q83178852 | ||
| P433 | issue | 1 | |
| P921 | main subject | von Hippel-Lindau disease | Q741315 |
| P304 | page(s) | 21-31 | |
| P577 | publication date | 2017-06-06 | |
| P1433 | published in | Journal of Endocrinological Investigation | Q15766847 |
| P1476 | title | Von Hippel-Lindau disease: a single gene, several hereditary tumors | |
| P478 | volume | 41 |
| Q96953732 | Application Areas of Traditional Molecular Genetic Methods and NGS in relation to Hereditary Urological Cancer Diagnosis |
| Q60931664 | Clinical Syndromes and Genetic Screening Strategies of Pheochromocytoma and Paraganglioma |
| Q64083362 | Distinctive clinicopathological features of Von Hippel-Lindau-associated hereditary renal cell carcinoma: A single-institution study |
| Q92156808 | Fibronectin in Cancer: Friend or Foe |
| Q64081971 | Genotype-phenotype relations of the von Hippel-Lindau tumor suppressor inferred from a large-scale analysis of disease mutations and interactors |
| Q92618041 | Hypoxia, cytokines and stromal recruitment: parallels between pathophysiology of encapsulating peritoneal sclerosis, endometriosis and peritoneal metastasis |
| Q92738656 | Is polycystic kidney disease associated with malignancy in children? |
| Q64076854 | Molecular Profiling of Druggable Targets in Clear Cell Renal Cell Carcinoma Through Targeted RNA Sequencing |
| Q57822415 | Oncometabolite induced primary cilia loss in pheochromocytoma |
| Q92432731 | PHEOCHROMOCYTOMA-PARAGANGLIOMA: TRANSLATIONAL APPROACH FROM GENETICS TO CLINICAL NEUROENDOCRINOLOGY |
| Q47097655 | Proteome profiling of clear cell renal cell carcinoma in von Hippel-Lindau patients highlights upregulation of Xaa-Pro aminopeptidase-1, an anti-proliferative and anti-migratory exoprotease. |
| Q46272231 | The E3 ubiquitin ligase Siah1 regulates adrenal gland organization and aldosterone secretion. |
| Q47577096 | Von Hippel-Lindau Disease With Multi-Organ Involvement: A Case Report and 8-Year Clinical Course With Follow-Up |
Search more.